OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PKIS.PSX57

Pakistan Oxygen Ltd

Commodity ChemicalsVerified

Pakistan Oxygen Limited maintains a conservative capital structure with a debt-to-equity ratio of 0.34, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.26, suggesting it can cover its short-term obligations but with limited buffer. Free cash flow stands at 1,634,440,000 PKR, supporting operational flexibility and potential reinvestment. Profitability metrics show a return on equity of 14.23% and a return on assets of 8.1%, both exceeding the typical thresholds for the Commodity Chemicals industry. The operating margin, derived from an operating income of 4,123,648,000 PKR on revenue of 13,047,286,000 PKR, indicates strong operational efficiency. These figures suggest the company is performing well relative to industry norms. The company's revenue is distributed across three main segments: Industrial, Medical, and Other Gases, and Welding and Others. The Industrial and Medical segments serve a broad range of industries, including oil and gas, healthcare, and food and beverage. The Welding and Others segment contributes to a more diversified revenue base, reducing exposure to any single market. Looking ahead, the company is projected to maintain a stable growth trajectory, supported by consistent revenue generation and positive cash flow. The capital expenditure of -909,822,000 PKR indicates a reduction in investment, which may signal a focus on optimizing existing assets rather than expansion. This approach could help sustain profitability in the near term. Risk factors include a medium liquidity risk, as the company's net cash position is negative after accounting for total debt. The dilution risk is assessed as low, with no significant dilution expected in the near term. The absence of a material difference between basic and diluted shares outstanding (87,124,228) further supports this assessment. Recent financial filings and disclosures show a strong earnings performance, with the last actual EPS reported at 9.74 PKR. This figure reflects the company's ability to generate consistent earnings, which is a positive indicator for investors. No recent significant events or regulatory actions have been reported that would impact the company's operations or financial health.

30-day price · PKIS.PSX+25.85 (+10.6%)
Low$225.60High$293.00Close$269.85As of12 May, 00:00 UTC
Profile
CompanyPakistan Oxygen Ltd
TickerPKIS.PSX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Pakistan Oxygen Limited produces and distributes industrial and medical gases, welding electrodes, and medical equipment, generating revenue primarily from the industrial, medical, and welding sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Pakistan Oxygen Limited maintains a conservative capital structure with a debt-to-equity ratio of 0.34, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.26, suggesting it can cover its short-term obligations but with limited buffer. Free cash flow stands at 1,634,440,000 PKR, supporting operational flexibility and potential reinvestment. Profitability metrics show a return on equity of 14.23% and a return on assets of 8.1%, both exceeding the typical thresholds for the Commodity Chemicals industry. The operating margin, derived from an operating income of 4,123,648,000 PKR on revenue of 13,047,286,000 PKR, indicates strong operational efficiency. These figures suggest the company is performing well relative to industry norms. The company's revenue is distributed across three main segments: Industrial, Medical, and Other Gases, and Welding and Others. The Industrial and Medical segments serve a broad range of industries, including oil and gas, healthcare, and food and beverage. The Welding and Others segment contributes to a more diversified revenue base, reducing exposure to any single market. Looking ahead, the company is projected to maintain a stable growth trajectory, supported by consistent revenue generation and positive cash flow. The capital expenditure of -909,822,000 PKR indicates a reduction in investment, which may signal a focus on optimizing existing assets rather than expansion. This approach could help sustain profitability in the near term. Risk factors include a medium liquidity risk, as the company's net cash position is negative after accounting for total debt. The dilution risk is assessed as low, with no significant dilution expected in the near term. The absence of a material difference between basic and diluted shares outstanding (87,124,228) further supports this assessment. Recent financial filings and disclosures show a strong earnings performance, with the last actual EPS reported at 9.74 PKR. This figure reflects the company's ability to generate consistent earnings, which is a positive indicator for investors. No recent significant events or regulatory actions have been reported that would impact the company's operations or financial health.
Key takeaways
  • Pakistan Oxygen Limited maintains a strong return on equity and assets, indicating efficient use of capital.
  • The company's debt-to-equity ratio is low, suggesting a conservative capital structure.
  • Revenue is diversified across multiple segments, reducing exposure to any single market.
  • Free cash flow is positive, supporting operational flexibility and potential reinvestment.
  • Liquidity risk is moderate, with a current ratio of 1.26.
  • Dilution risk is low, with no significant dilution expected in the near term.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyPKR
Revenue$13.05B
Gross profit$5.24B
Operating income$4.12B
Net income$1.67B
R&D
SG&A
D&A
SBC
Operating cash flow$3.70B
CapEx-$909.8M
Free cash flow$1.63B
Total assets$20.60B
Total liabilities$8.87B
Total equity$11.73B
Cash & equivalents
Long-term debt$4.03B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$11.73B
Net cash-$4.03B
Current ratio1.3
Debt/Equity0.3
ROA8.1%
ROE14.2%
Cash conversion2.2%
CapEx/Revenue-7.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricPKIS.PSXActivity
Op margin31.6%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin12.8%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin40.2%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-7.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity34.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS9.74 PKR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:42 UTC#f7fc1592
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:45 UTCJob: f5035c77